Lv3
240 积分 2024-02-06 加入
The Biomarkers for Bevacizumab in first-line chemotherapy
2天前
已完结
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
1个月前
已完结
Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
1个月前
已关闭
The present and future of bispecific antibodies for cancer therapy
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
3个月前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
3个月前
已完结
Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta‐analysis
4个月前
已完结
Advances in cutaneous squamous cell carcinoma
4个月前
已完结
Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes
5个月前
已完结
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms
5个月前
已完结
皖公网安备34019202002308
